Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Surgical Oncology
Erschienen in: Annals of Surgical Oncology 10/2016

18.07.2016 | Breast Oncology

Breast Cancer Survivorship: Why, What and When?

verfasst von: Jennifer Gass, MD, Beth Dupree, MD, Sandhya Pruthi, MD, Diane Radford, MD, Irene Wapnir, MD, Reza Antoszewska, ANP-C, Audrey Curtis, MD, Nathalie Johnson, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Survivorship medicine is fairly new in the realm of oncology. As we broaden our focus from treatment and prevention to include survivorship there is substantial opportunity to enhance the care of the patient. Important in successful management of recovery after cancer treatment is managing the side effects of therapy and improving quality of life. This ranges from sexual dysfunction, depression to lymphedema. Guideline-based surveillance after treatment with clear communication of care plans to the patient and their providers, especially primary care, is paramount. Thoughtful pre-surgical treatment planning, which may include neoadjuvant approaches or consideration of fertility preservation, results in superior long-term patient outcomes. Understanding the importance of the teachable moment in effecting behavioral and lifestyle changes that reduce risk of recurrence is also an essential component of excellent cancer survivor patient care. We identified the following areas for focus as they represent the key areas for accreditation and patient driven needs. Development of survivorship plans, post treatment surveillance, sexuality and fertility preservation, lymphedema management and risk reduction lifestyle and behavioral changes.
Literatur
1.
2.
3.
4.
Khatcheressian JL, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961–5.CrossRefPubMed
5.
Runowicz CD, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol. 2016;34(6):611–35.CrossRefPubMed
6.
Winters-Stone K, Hilton CM, Luoh SW, et al. Comparison of physical function and falls among women with persistent symptoms. 2016.
7.
Brennan ME, et al. Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer. 2014;111(10):1899–908.CrossRefPubMedCentral
8.
Bulloch KJ, et al. Systematic approach to providing breast cancer survivors with survivorship care plans: a feasibility study. J Oncol Pract. 2015;11(2):e170–6.CrossRefPubMed
9.
Rowland JH, Bellizzi KM. Cancer survivorship issues: life after treatment and implications for an aging population. J Clin Oncol. 2014;32(24):2662–8.CrossRefPubMedPubMedCentral
10.
Grunfeld E, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29(36):4755–62.CrossRefPubMed
11.
Berman AT, et al. Use of survivorship care plans and analysis of patient-reported outcomes in multinational patients with lung cancer. J Oncol Pract. 2016;12(5):e527–35.CrossRefPubMed
12.
13.
Lehman CD, et al. Screening MRI in women with a personal history of breast cancer. J Natl Cancer Inst. 2016;108(3):djv349CrossRefPubMed
14.
Houssami N, et al. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomarkers Prev. 2013;22(5):946–61.CrossRefPubMedPubMedCentral
15.
Shah, A., et al., Building a rapid learning health care system for oncology: why CancerLinQ collects identifiable health information to achieve its vision. J Clin Oncol. 2016;34(7):756–63.CrossRefPubMed
16.
Administration, F.A.D., Silicone gel-filled breast implants: updated safety information, 2011.
17.
Baynosa J, et al. Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. J Am Coll Surg. 2009;209(5):603–7.CrossRefPubMed
18.
Munhoz RR, et al. Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: a systematic review and meta-analysis. JAMA Oncol. 2016;2(1):65–73.CrossRefPubMed
19.
20.
Azim HA Jr., et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol. 2013;31(1):73–9.CrossRefPubMed
21.
Avis NE, Crawford S, Manuel J. Psychosocial problems among younger women with breast cancer. Psychooncology. 2004;13(5):295–308.CrossRefPubMed
22.
Meyerowitz BE, et al. Sexuality following breast cancer. J Sex Marital Ther. 1999;25(3):237–50.CrossRefPubMed
23.
Fobair P, et al. Body image and sexual problems in young women with breast cancer. Psychooncology. 2006;15(7):579–94.CrossRefPubMed
24.
Gochros JFH. Approaches to specific problems. In: Handbook of behavior therapy with sexual problems, 1st edn. Elsevier, 2013:388
25.
American College of Obstetrics and B.-G. Gynecologists Committee on Practice, ACOG Practice Bulletin No. 119: female sexual dysfunction. Obstet Gynecol. 2011;117(4):996–1007.CrossRef
26.
Committee Opinion No. 659: The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol. 2016;127(3):e93–6.CrossRef
27.
Schover LR, et al. Partial mastectomy and breast reconstruction. A comparison of their effects on psychosocial adjustment, body image, and sexuality. Cancer. 1995;75(1):54–64.CrossRefPubMed
28.
Ganz PA, et al. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16(2):501–14.PubMed
29.
Ganz PA, et al. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol. 1999;17(8):2371–80.PubMed
30.
Rowland JH, et al. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst. 2000;92(17):1422–9.CrossRefPubMed
31.
Burwell SR, et al. Sexual problems in younger women after breast cancer surgery. J Clin Oncol. 2006;24(18):2815–21.CrossRefPubMed
32.
Pozo C, et al. Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery. J Clin Oncol. 1992;10(8):1292–8.PubMed
33.
Yurek D, Farrar W, Andersen BL. Breast cancer surgery: comparing surgical groups and determining individual differences in postoperative sexuality and body change stress. J Consult Clin Psychol. 2000;68(4):697–709.CrossRefPubMedPubMedCentral
34.
Arora NK, et al. Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study. Cancer. 2001;92(5):1288–98.CrossRefPubMed
35.
Parker PA, et al. Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol. 2007;14(11):3078–89.CrossRefPubMed
36.
37.
Engel J, et al. Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J. 2004;10(3):223–31.CrossRefPubMed
38.
Aerts L, et al. Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study. Breast. 2014;23(5):629–36.CrossRefPubMed
39.
Gerber B, et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg. 2003;238(1):120–7.PubMedPubMedCentral
40.
Wang F, et al. Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes. Ann Surg Oncol. 2014;21(10):3223–30.CrossRefPubMed
41.
Petit JY, et al. When mastectomy becomes inevitable: the nipple-sparing approach. Breast. 2005;14(6):527–31.CrossRefPubMed
42.
Rivadeneira DE, et al. Skin-sparing mastectomy with immediate breast reconstruction: a critical analysis of local recurrence. Cancer J. 2000;6(5):331–5.PubMed
43.
Didier F, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? Breast Cancer Res Treat. 2009;118(3):623–33.CrossRefPubMed
44.
Robinson VC. Support for the hypothesis that sexual breast stimulation is an ancestral practice and a key to understanding women’s health. Med Hypotheses. 2015;85(6):976–85.CrossRefPubMed
45.
Levin R. The breast/nipple/areola complex and human sexuality. Sex Relation Ther. 2006;21(2):237–49.CrossRef
46.
Wei CH, et al. Psychosocial and sexual well-being following nipple-sparing mastectomy and reconstruction. Breast J. 2016;22(1):10–7.CrossRefPubMed
47.
Kwait R, Pesek S, Onstad M, Edmonson D, Ghandi C, Raker C, Stuckey A, Gass J. ASBrS Poster: Preserving sexual function in breast cancer survivorship: does surgical modality matter? 2016.
48.
Goldberg JI, et al. Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol. 2010;17(12):3278–86.CrossRefPubMed
49.
Caudle AS, Thompson AM. Less remains better: morbidity after axillary surgery. Ann Surg Oncol. 2015;22(1):4–6.CrossRefPubMed
50.
Boughey JC, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455–61.CrossRefPubMedPubMedCentral
51.
Boneti C, et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg. 2008;206(5):1038–42 (discussion 1042–4).CrossRefPubMed
52.
Passerelli MN, Hampton J, et al. Cigarette smoking before and after a breast cancer diagnosis: mortality from breast cancer and smoking related diseases. J Clin Oncol. 2016.
53.
Norman SA, et al. Modifiable risk factors for breast cancer recurrence: what can we tell survivors? J Womens Health (Larchmt). 2007;16(2):177–90.CrossRef
54.
Lara Heflin SF, DeLuca AN, Melisko ME, Moasser MM, Park JW, Chien AJ, Munster PN, Landau SM, Jagust WJ, Kramer JH, Rugo HS. Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): relationship between perceived and measurable cognitive deficits. J Clin Oncol. 2013.
55.
Dabrowski M, et al. Clinical experience with the NCCN distress thermometer in breast cancer patients. J Natl Compr Cancer Netw. 2007;5(1):104–11.PubMed
56.
Haque R, et al. Tamoxifen and antidepressant drug interaction in a cohort of 16,887 breast cancer survivors. J Natl Cancer Inst. 2016;108(3):djv337.CrossRefPubMed
57.
58.
59.
60.
Metadaten
Titel
Breast Cancer Survivorship: Why, What and When?
verfasst von
Jennifer Gass, MD
Beth Dupree, MD
Sandhya Pruthi, MD
Diane Radford, MD
Irene Wapnir, MD
Reza Antoszewska, ANP-C
Audrey Curtis, MD
Nathalie Johnson, MD
Publikationsdatum
18.07.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5403-0

Weitere Artikel der Ausgabe 10/2016

Annals of Surgical Oncology 10/2016 Zur Ausgabe

Breast Oncology

Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks

Breast Oncology

Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer

Breast Oncology

Acute and Chronic Complications in Breast Cancer Patients Treated with Intraoperative Radiation Therapy

Breast Oncology

Intraoperative Margin Assessment in Wire-Localized Breast-Conserving Surgery for Invasive Cancer: A Population-Level Comparison of Techniques

Breast Oncology

Dense Breasts: What Do Our Patients Need to Be Told and Why?

Breast Oncology

A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.